Inventor

ROMMELAERE HEIDI

BE11 patents

⚠️ This page may combine multiple inventors who share the name “ROMMELAERE HEIDI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABLYNX NV

8 patents

US11208476B2Dec 28, 2021

Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP

ABLYNX NV12 citations83

US11840566B2Dec 12, 2023

Methods of treating asthma with polypeptides targeting IL-13 and TSLP

ABLYNX NV1 citations70

US11332525B2May 17, 2022

Polypeptides comprising immunoglobulin single variable domains targeting TNFA and IL-23

ABLYNX NV4 citations69

US11897951B2Feb 13, 2024

Polypeptides comprising immunoglobulin single variable domains targeting IL-6 and TNF-α

ABLYNX NV3 citations67

US12528860B2Jan 20, 2026

Polypeptides comprising immunoglobulin single variable domains targeting TNFα and IL-23

ABLYNX NV0 citations59

US12492248B2Dec 9, 2025

Methods of treatment utilizing polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP

ABLYNX NV0 citations59

US12384840B2Aug 12, 2025

Nucleic acids encoding polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP

ABLYNX NV0 citations59

US12509522B2Dec 30, 2025

Polypeptides comprising immunoglobulin single variable domains targeting il-13 and OX40L

ABLYNX NV0 citations47

MERCK PATENT GMBH

2 patents

US10829552B2Nov 10, 2020

Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same

MERCK PATENT GMBH1 citations70

US11773159B2Oct 3, 2023

Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same

MERCK PATENT GMBH0 citations60

ROMMELAERE HEIDI

1 patent

US10017568B2Jul 10, 2018

Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment using same

ROMMELAERE HEIDI3 citations65